8Emmert Buck

Embed Size (px)

Citation preview

  • 7/29/2019 8Emmert Buck

    1/7

    Michael R. Emmert-Buck, MD, PhD

    Pathogenetics Unit

    Laser Capture Microdissection Core

    Laboratory of Pathology

  • 7/29/2019 8Emmert Buck

    2/7

    Specimen Workflow:

    Patient or Model System

    Tissue Processing

    Molecular Analysis

    Further Research;

    Clinical Impact

    Pathogenetics Unit

    Laboratory MissionDevelop technologies for tissue analysis

    Pathogenetics Unit

    1. Laser Dissection

    2. In Situ Methods

  • 7/29/2019 8Emmert Buck

    3/7

    NIH Collaborators:

    Bob Bonner, Tom Pohida,

    Paul Smith, Seth Goldstein,

    Lance Liotta, Zhengping Zhuang

    Tissue

    Pathogenetics Unit

    1991 2013Development Timeline

    Arcturus PixCell

    (First 10 Years)

    Arcturus XT

    (Second 10 Years)

    Applications

    Animal Model

    Clinical Specimens

    Plants

    In vitro Cultures

    Live Cell

    LCM Cores

    Over 100

    Publications

    ~ 3,000

    1991-95

    Prototypes

    1996-2001

    LCM

    2001-13

    Improvements

    2001-13

    Applications

    Example = LCM

    As of 2013

  • 7/29/2019 8Emmert Buck

    4/7

    Tissue

    Pathogenetics Unit

    1991 2013Development Timeline

    1991-95

    Prototypes

    1996-2001 2001-13

    ImprovementsLCM

    2004-13

    Automation xMD

    2004-13 2009-13

    SIVQ

    PGUMike Tangrea

    University of Michigan

    Ulysses BalisJerome Chang

    NIH Collaborators

    LCM Core

    Applications

    2001-13

    Current Focus Automation xMD, SIVQ-LCM

    1) High-throughput (xMD; SIVQ-LCM)

    2) Precision (xMD)

    3) Low Cost Kit (xMD)

    4) Visualization (xMD)

    5) Beta-testing - LCM Core; U-M (xMD; SIVQ-LCM)

    6) Commercial Partner (xMD; SIVQ-LCM)

  • 7/29/2019 8Emmert Buck

    5/7

    1991 2013

    Most ImportantAccomplishments

    Pathogenetics Unit

    Nathan - 2000 Emily - 2002 Alicia - 2005

    1991-95

    Prototypes

    1996-2001

    LCM

    2001-13

    Improvements

    2001-13

    Applications

    2004-13

    Automation

    2004-13

    xMD

    2009-13

    SIVQ

    Development Timeline

  • 7/29/2019 8Emmert Buck

    6/7

    Tissue

    Pathogenetics Unit

    xMD, SIVQ-LCM

    Applications,

    Commercialize

    2013 2031

    Next Twenty Years

    Clinical Utility of

    Laser Dissection

    ??

    Future questions to address

    What is the role of laser dissection, if any, in moleculardiagnostics?

    Is there a compelling need?

    Does cell purity matter in clinical assays?

    - DNA mutation testing? NGS?- mRNA? miRNA?

    - Proteomics?

    Is there a need for a new meeting or working group?

    Clinical

    Microdissection

    Working Group

    NIH Collaborators

    Mark Raffeld, ArmandoFilie, Liqiang Xi, LCM

    Core

  • 7/29/2019 8Emmert Buck

    7/7

    Pathogenetics Unit

    CollaboratorsLCM, xMD Extramural

    Robert Bonner Ben Shapiro

    Thomas Pohida Elisabeth Smela

    Nicole Morgan Clinical Dissection WG

    Don JohannLaboratory of Pathology

    Avi Rosenberg SIVQ-LCM

    Armando Filie Ulysses Balis

    Mark Raffeld Jerome Chang

    Liqiang Xi

    Maria Merino MEN1

    Elaine Jaffe Stephen Marx

    Jason Hipp Sunita Agarwal

    Stephen Hewitt

    Mark Roth